Cargando…

Unexpected increase in the bone marrow toxicity of mitomycin C (MMC) – reply

Detalles Bibliográficos
Autores principales:	Imai, Y, Hagiwara, T
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2001
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363800/ http://dx.doi.org/10.1054/bjoc.2000.1670

Ejemplares similares

Unexpected increase in the bone marrow toxicity of mitomycin C (MMC)
por: Yoshimoto, Masataka, et al.
Publicado: (2001)

Intravesical mitomycin C (MMC) and MMC + cytosine arabinoside for non‐muscle‐invasive bladder cancer: a randomised clinical trial
por: Miyata, Yasuyoshi, et al.
Publicado: (2021)

Reply: Capecitabine and mitomycin C in patients with metastatic colorectal cancer resistant to fluorouracil and irinotecan
por: Chong, G, et al.
Publicado: (2006)

Surgical outcome of conjunctival rotational autograft-mitomycin C (MMC) versus free conjunctival autograft-MMC for pterygium removal: A randomized clinical trial
por: Bamdad, Shahram, et al.
Publicado: (2017)

Reply to comments on: Intraoperative injection versus sponge—Applied mitomycin C during trabeculectomy: One - year study
por: Maheshwari, Devendra, et al.
Publicado: (2021)

Endoplasmic Reticulum Stress Signaling Is Involved in Mitomycin C(MMC)-Induced Apoptosis in Human Fibroblasts via PERK Pathway
por: Shi, Kun, et al.
Publicado: (2013)

Injected Versus Sponge-Applied Mitomycin C (MMC) During Modified Trabeculectomy in New Zealand White Rabbit Model
por: Swogger, John, et al.
Publicado: (2020)

Comparative evaluation of outcomes of novel approach of subconjunctival Mitomycin C (MMC) injection at the end of trabeculectomy versus intraTenon injection of MMC prior to the initial conjunctival incision – A pilot study
por: Gupta, Ved Prakash, et al.
Publicado: (2022)

The Authors' Reply to “A Bone Marrow Biopsy Is Mandatory for a Diagnosis of Essential Thrombocythemia”
por: Kato, Yuji, et al.
Publicado: (2019)

Determination of the Protein-Protein Interactions within Acyl Carrier Protein (MmcB)-Dependent Modifications in the Biosynthesis of Mitomycin
por: Leng, Dongjin, et al.
Publicado: (2021)

Capecitabine and mitomycin C in patients with metastatic colorectal cancer resistant to fluorouracil and irinotecan
por: Alliot, C
Publicado: (2006)

In reply
por: Iwasawa, Tae, et al.
Publicado: (2020)

Reply
por: Yoshida, Shuhei, et al.
Publicado: (2021)

Reply to “Pulmonary toxicity by oxygen and COVID-19”()
por: Belenguer-Muncharaz, A., et al.
Publicado: (2022)

Pre-operative sub-conjunctival mitomycin C 24 hours before excision of recurrent pterygium
por: Gupta, V P, et al.
Publicado: (2013)

Authors’ reply: A rare presentation of methanol toxicity
por: Gupta, Nikhil, et al.
Publicado: (2013)

Preoperative Subconjunctival Injection of Mitomycin C as an Adjunctive Treatment 24 Hours Before Excision of Primary Pterygium
por: Gupta, Ved P., et al.
Publicado: (2012)

Comments on: Intraoperative injection versus sponge-applied mitomycin C during trabeculectomy: One-year study
por: Latsaheb, Brenda, et al.
Publicado: (2021)

Comments on: Intraoperative injection versus sponge applied mitomycin C during trabeculectomy: One year study
por: Bansal, Tanima, et al.
Publicado: (2021)

Differential Toxicity of DNA Adducts of Mitomycin C
por: Bargonetti, Jill, et al.
Publicado: (2010)

Bone and Bone Marrow Involvement in Sarcoidosis
por: Sargın, Gökhan, et al.
Publicado: (2014)

Response to comments on: Intraoperative injection versus sponge—applied Mitomycin C during trabeculectomy: One-year study
por: Maheshwari, Devendra, et al.
Publicado: (2021)

Reply: CIITA methylation and decreased levels of HLA-DR in tumour progression
por: Morimoto, Y, et al.
Publicado: (2004)

Comments on: Mid-term outcome of mitomycin C-augmented trabeculectomy in open-angle glaucoma versus angle-closure glaucoma
por: Pathak-Ray, Vanita
Publicado: (2020)

Response to comments on: Midterm outcome of mitomycin C augmented trabeculectomy in open angle glaucoma versus angle-closure glaucoma
por: Maheshwari, Devendra, et al.
Publicado: (2020)

Unexpected increase of the compliance rate of transfusion requisition form after the COVID-19 outbreak
por: Yang, L., et al.
Publicado: (2021)

In reply to “Anti-alpha-enolase antibodies in membranous nephropathy: isotype matters”
por: Imai, Hirokazu, et al.
Publicado: (2016)

Authors’ reply (acute myocardial infarction and cocaine toxicity: One step closer)
por: Sarkar, Achyut, et al.
Publicado: (2014)

In Reply
por: de Velasco, Guillermo, et al.
Publicado: (2017)

Ultrasound-guided sternal bone marrow aspiration
por: Asakura, Yusuke, et al.
Publicado: (2017)

Reply to “Bone morphogenetic protein's contribution to pulmonary artery hypertension”
por: King, Tyler, et al.
Publicado: (2016)

Author's Reply
por: Madanat, Amal Y., et al.
Publicado: (2017)

Use of Bone Marrow‐Derived Mesenchymal Stem Cells in Prostate Cancer Could Increase the Risk of Cancer Progression
por: Raj, A. Thirumal, et al.
Publicado: (2019)

Expect the unexpected
por: Rathee, Manu
Publicado: (2014)

Toxic anterior segment syndrome following trabeculectomy with mitomycin C
por: Ginger-Eke, Helen, et al.
Publicado: (2023)

Authors’ reply
por: Shanmugam, Mahesh P, et al.
Publicado: (2015)

BCG+MMC trial: adding mitomycin C to BCG as adjuvant intravesical therapy for high-risk, non-muscle-invasive bladder cancer: a randomised phase III trial (ANZUP 1301)
por: Hayne, Dickon, et al.
Publicado: (2015)

Conservative treatment for high-risk NMIBC failing BCG treatment: who benefits from adding electromotive drug administration (EMDA) of mitomycin C (MMC) to a second BCG induction cycle?
por: Busetto, Gian Maria, et al.
Publicado: (2023)

Author`s Reply
por: Taher, Ziad A., et al.
Publicado: (2019)

Pancytopenia with cellular bone marrow related to Graves’ hyperthyroidism
por: Raina, Sujeet, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_p9o59cs86vgksc6inhvrvjlel4